Global Alopecia Market Size Set For Moderate Growth, To Reach Value around USD 4.98 Billion by 2032
The Global Alopecia Market size was worth around USD 2.49 Billion in 2023 and is estimated to grow to about USD 4.98 Billion by 2032, with a compound annual growth rate (CAGR) of approximately 8.00% over the forecast period.
Zion Market Research has published a new report titled “Alopecia Market By Disease (Androgenic Alopecia, Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, And Others, By Drug Type (Corticosteroids, 5 Ar Inhibitors And Others), By Gender (Male, Female); By Route Of Administration (Topical, Injectable And Oral) And Distribution Channel (Retail Pharmacies, Hospital Pharmacies And Online Pharmacies), And By Region — Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032”.
The word alopecia means hair loss. Alopecia isn’t limited to the scalp; it’s possible on the body anywhere. The hair cycle comprises of three phases: Anagen, which is called as growth phase. Second phase is catagen, also called as rest phase and the fading phase, which is called as telogen phase. Ninety percent of the hair is in the development period (anagen) and the remaining, which corresponds to ten percent in the resting and shedding phases. When the hair falls out, this is the telogen phase and the hair is going to regenerate, and it begins to develop again in the (development) anagen process. Alopecia can be subdivided into two broad categories: scarring and non-scarring. Non-scarring or androgenic alopecia is the most common form. Many men start losing hair in the 20s, while women start losing their hair in their 40s or 50s. As a person grows older they lose hair. The pattern is the disparity between masculine hair loss and female hair loss. Front and temporal zone are the area where men usually lose hair because this area is more sensitive to di-hydrogen testosterone. while women appear to lose hair from the scalp’s central field. Female hair loss will also not result in complete baldness, while male hair loss can result in complete baldness. Males do not loose hair in the back of the scalp as this area is androgenic hormone resistant.
Increasing prevalence of hair loss, technological advancements in alopecia treatment, and the rise in prevalence of chronic diseases that are associated with hair loss are some of the major factors driving the market growth globally. According to data published by the American Hair Loss Association, it was stated that over 95% of hair loss in men is caused due to androgenetic alopecia. Similarly, data published by the International Society of Hair Restoration Surgery, it was estimated that nearly 40% of men encounter some degree of hair loss by 35 years of age, 65% at 60 years, 70% at 80 years, and 80% at the age of 85.Owing to these factors, the androgenetic alopecia market size in terms of revenue is estimated to grow at a significant growth rate during the forecast period.
The growing prevalence of hair loss is one of the major factors driving the alopecia treatment market. According to data published by the Journal of Clinical and Diagnostic Research (JCDR), around 60% of the global population has hair thinning problems and pattern hair loss is the most common form of hair loss in both males and females. Moreover, around 2% of the global population is at risk of developing alopecia areata in their lifetime globally, irrespective of gender.
The global rise in healthcare expenditure is also a major factor in the market’s growth. Major countries in North America, Asia Pacific, Latin America, and Europe are witnessing a significant increase in per capita healthcare expenditure. For instance, according to the American Medical Association article published in March 2023, the healthcare expenditure in the U.S. increase by 2.7% in 2021 than previous year to USD 12,914 per capita or USD 4.3 trillion. Moreover, according to the Office for National Statistics (ONS) article published in May 2023, the UK’s healthcare expenditure in 2022 was approximately USD 304.55 billion, an increase of 0.7% over the previous year.
The global demand for alopecia market is driven by fluctuating lifestyles leading to increasing levels of stress among the working class, increased geriatric population, high demand for surgical hair transplants and increased customer awareness of possible treatment like prp treatment are expected to drive the growth of the alopecia industry. In addition, the rise in the occurrence of chronic diseases, like acute stress disorder, polycystic ovary disease (PCOD), hyperthyroidism, hypothyroidism, cancer, lupus, and hypopituitarism, is projected to accelerate sales growth over the forecast era .However, high cost of disease and adverse effects of disease may act as restraining factors for the market growth in the coming years. Economic growth paired by continuously growing medical expenditure is projected to bring new growth opportunities for market players during the forecast timeframe.
Based on disease type, global alopecia market is segmented into androgenic alopecia, alopecia areata, cicatricial alopecia, traction alopecia, alopecia totalis, alopecia universalis, and others. Market was dominated by alopecia areata disease type segment in 2019. This is because alopecia areata is mostly predominant in people suffering with various autoimmune diseases, diabetes, and hyperthyroidism. Androgenic alopecia is expected to show the highest progress, largely fueled by the anticipated launch of several promising therapy and drugs for the pipeline and an increasing rate of incidence. Androgens cause the trigger for alopecia in people with inherited inclination. Various therapeutic approaches for androgenic alopecia, which inhibits 5-alpha reductase, such as approved oral, topical, and surgical therapies are available.
Based on drug type market is segmented into 5 ar inhibitors, potassium channel openers, corticosteroids and others. Market was dominated by corticosteroids drug type segment 2023. On the other hand 5 AR inhibitors segment will register highest growth rate during the forecast period due to increasing male pattern baldness.
Based on gender, global market is segmented into male, female. Market was dominated by male segment in 2023. This is attributed to increased occurrence of androgenic alopecia in male.
Based on route of administration, global market is segmented into injectable, oral and topical. Market was dominated by topical administration route segment in 2023.
The distribution channel segment of the Alopecia market is categorized into retail pharmacies, hospital pharmacies and online pharmacies. Among all distribution channels, retail pharmacies dominated the market in 2019 with largest revenue share. Online pharmacies are expected to witness rapid growth in the years to come.
North America held largest revenue share of the global Alopecia market in 2023. This large share is attributed to large alopecia patient pool, availability of developed infrastructure, growing awareness and presence of key players in this region. Europe was second leading regional market in terms of revenue. Availability of developed infrastructure, increasing alopecia prevalence, and growing awareness are major factors that support market growth in this region. Asia Pacific region is projected to be rapidly growing regional market for Alopecia. Increasing alopecia and geriatric population base, economic development, improvement of healthcare infrastructure, increasing disposable income and healthcare spending, growing awareness are major factors attributing to the swift growth in this region. Moderate growth is projected in Latin America region over the forecast period. Middle East and Africa will witness sluggish growth in the coming years.
Alopecia Market: Competitive Players
Key players within the global Alopecia market include
- Cipla Inc.
- Dr. Reddy’s Laboratories
- Johnson and Johnson AG
- Ranbaxy Laboratories Ltd
- Transitions Hair Pty Ltd.
- Sun Pharmaceutical Industries Ltd.
- Merck & Co.Inc.
- Transitions Hair Pty Ltd
- Cirrus Hair Centers
- Lexington International LLC
- Vita-Cos-Med Klett-Loch GmbH
- Follica.Inc.
- Capillus.
- among others.
The report segment of global alopecia market as follows:
Global Alopecia Market: Disease Type
- Alopecia Areata
- Androgenic Alopecia
- Cicatricial Alopecia
- Traction Alopecia
- Alopecia Totalis
- Alopecia Universalis
- Others
Global Alopecia Market: By Drug Type
- Corticosteroids
- 5 AR Inhibitors
- Potassium Channel openers
- Others
Global Alopecia Market: By Gender
- Male
- Female
Global Alopecia Market: By Route of Administration
- Topical
- Oral
- Injectable
Global Alopecia Market: By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Alopecia Market: By Region
- North AmericaThe U.S.Canada
- EuropeFranceThe UKSpainGermanyItalyRest of Europe
- Asia PacificChinaJapanIndiaSouth KoreaSoutheast AsiaRest of Asia Pacific
- Latin AmericaBrazilMexicoRest of Latin America
- Middle East & AfricaGCCSouth AfricaRest of Middle East & Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us — after all — if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49–322 210 92714 USA/Canada Toll-Free №1–855–465–4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com